Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Kovas Co., Ltd.
EIR
•Kovas Co., Ltd.•November 22, 2019

Kovas Co., Ltd. – FDA EIR, Nov 22, 2019

Record Details

An FDA inspection of Kovas Co., Ltd., an Over-the-Counter (OTC) drug manufacturer, was conducted from November 18-22, 2019. This routine Current Good Manufacturing Practice (CGMP) inspection, performed under Compliance Program 7356.002, covered all six critical systems: Quality, Facilities and Equipment, Laboratory Control, Materials, Production, and Packaging and Labeling. The inspection concluded with the issuance of a 22-item FDA-483, detailing significant observations. Key issues included failures in software validation, electronic system access control, and data backup. Laboratory controls were deficient, with improper reference standards, incomplete testing of received components, and inadequate microbial analysis methods and reference standard characterization. Equipment design, maintenance, and logging were found lacking, alongside the use of uncalibrated weights. Material management issues encompassed improper sampling of raw materials and components, and inadequate maintenance and visual verification of reserve samples. Furthermore, documentation and quality assurance problems involved incomplete packaging batch records, insufficient control over records and procedures, and unestablished yield percentages. Finally, employee training on CGMP requirements was identified as insufficient. Kovas Co., Ltd. management acknowledged these observations and committed to providing a written response with proposed corrections within fifteen working days.

Company
Kovas Co., Ltd.
Inspection date
November 22, 2019
Product type
OTC (Over-the-Counter)
Office
Office of Regulatory Affairs
People
  • Christopher D. Leach (Compliance Officer at FDA)
  • Yasamin Ameri (Compliance Officer)
  • Sandra A. Boyd (Drug National Expert)
View Company Profile

ID · 86bffd09-2faa-49ae-b669-675d6413aa42

Violation Codes1
21 CFR 211

Full citation text and observation details available on the Dashboard.

Other documents for Kovas Co., Ltd.
  • 483 - 2024-11-29November 29, 2024
  • EIR - 2024-11-29November 29, 2024
  • 483 - 2019-11-22November 22, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kovas Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.